556
edits
Changes
Jump to navigation
Jump to search
→Portfolio
==Portfolio==
*Accelerox
**ACELEROX is developing novel antioxidant nanoparticles that serve as therapies for reactive oxygen species (ROS)-mediated disease. ROS has been implicated in the progression of a broad range of diseases, including rheumatoid arthritis, multiple sclerosis, ischemic stroke and traumatic brain injury. The company’s proprietary class of molecules, termed PEG-HCCs, can be used to directly treat the symptoms of these diseases as well as to deliver chemotherapeutic drugs into tumors.
*ACF Pharmaceuticals
**
*Apaxis Medical
*Brevitest Technologies
